Xanthelasma Removal: What Those Yellow Eyelid Patches Actually Are
Those Yellow Patches Near Your Eyes Aren't Just a Cosmetic Thing (But They Are Fixable)
If you've noticed a soft, flat, yellowish patch settling in near the inner corner of your upper or lower eyelid, you're looking at something called xanthelasma. It's harmless in the sense that it won't hurt you, but it tends to sit right where people look first, which is exactly why so many patients want it gone.
What's Actually Going On
Xanthelasma is a build-up of cholesterol sitting just under the thin skin of the eyelid. The skin there is some of the thinnest on the body, which is part of why these deposits show up so visibly and so early compared to similar cholesterol deposits elsewhere.
It's genuinely uncommon in the broader population. Research places the incidence at somewhere between 0.56% and 1.5% of people in Western countries, most often appearing between the ages of 40 and 60. It also tends to be noticed more often in women, though that may simply come down to who's more likely to raise it as a cosmetic concern in the first place.
Is It Just Cosmetic, or Something Else?
Mostly cosmetic, yes. But it's worth knowing that xanthelasma has a recognised link to blood cholesterol levels, and a systematic review and meta-analysis found an association between xanthelasma and increased risk factors for atherosclerosis. That doesn't mean everyone with these patches has a cardiac problem, plenty of people with completely normal cholesterol develop them too, but it's a reasonable prompt to mention it to your GP if you haven't had your levels checked recently.
The removal itself is a separate decision from that conversation. You can absolutely have the patches treated for how they look while also getting your cholesterol checked as general good practice.
What Removal Actually Involves
Dr Hung Nguyen (AHPRA registration MED0001176347) assesses each case individually before recommending an approach, since the right technique depends on the size, depth and number of patches present. At Skinnotion, xanthelasma is typically addressed using radiofrequency-based removal with our Surgitron RF device, which allows precise removal of the affected tissue with minimal disruption to the surrounding eyelid skin.
Why the eyelid area gets extra care: because the skin here is so thin, technique and precision matter more than they would almost anywhere else on the face. This is a big part of why it's assessed and performed by a doctor rather than treated as a routine cosmetic add-on.
Recovery is generally straightforward. Expect some mild redness or a small scab at the treatment site in the days afterwards, settling over one to two weeks. For larger or thicker patches, a small stitch or two is sometimes needed to close the treated area cleanly, in which case a short follow-up visit is arranged for suture removal, usually about five to seven days later. Dr Nguyen will let you know at your consultation whether your case is likely to need this step.
One thing worth being upfront about: xanthelasma has a genuine tendency to return over time, particularly if cholesterol levels remain elevated, so it's reasonable to think of removal as treating what's there now rather than a permanent guarantee against new patches forming later.
What to Watch For
- Rapid growth or a change in colour or texture, which warrants an assessment rather than assuming it's the same thing.
- Multiple patches appearing at once, which is worth flagging alongside a cholesterol check.
- Any patch that becomes painful or irritated, since xanthelasma itself is typically painless.
Book an Assessment
If you've noticed a yellowish patch near your eyes and want it properly assessed, a consultation with Dr Hung Nguyen is the place to start. You can learn more about xanthelasma removal here, or call us to talk it through first.
Keep Exploring
Further Reading
Nair & Singhal (2017), Clinical, Cosmetic and Investigational Dermatology: a review of xanthelasma palpebrarum, incidence and treatment options.
Chang, Sung & Lin (2020), Journal of the American Academy of Dermatology: systematic review and meta-analysis on xanthelasma and atherosclerotic risk.